PPARA and Insulin resistance: With the awareness that PPAR agonists can have significant off-target adverse effects [63,64], together with evidence that soy protein and isoflavones positively impact insulin resistance [55,56,65] and could potentially prevent FASD [57], we designed an experiment to evaluate the therapeutic or preventive effects of soy isolate on brain pathology in an established model of chronic ethanol feeding.